HAPLN1
Summary:
Loading, please wait...
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
OMIM IDMIM:115435 Ensembl IDEnsembl:ENSG00000145681 HGNC IDHGNC:HGNC:2380 PHARMGKB IDPA26901 Map Location5q14.3 |
Gene Categories:
DRUGGABLE GENOMEGO terms in HAPLN1
Loading, please wait...
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | HDA | GO:0030021 | extracellular matrix structural constituent conferring compression resistance |
BP | IBA | GO:0001501 | skeletal system development |
BP | IEA | GO:0007155 | cell adhesion |
BP | IBA | GO:0007417 | central nervous system development |
BP | TAS | GO:0030198 | extracellular matrix organization |
CC | TAS | GO:0005576 | extracellular region |
Gene expression in normal tissue: HAPLN1
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in HAPLN1
Loading, please wait...
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-1474244 | Extracellular matrix organization |
reactome | R-HSA-3000178 | ECM proteoglycans |
Showing 1 to 2 of 2 rows
Gene-Drug: Aster Plot
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in HAPLN1
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |